Microbiological Indicators of Patients with Confirmed Sars-Cov-2 - Infection
Keywords:
antibiotic resistance, COVID-19, pneumonia, SARS-CoV-2, sputum culture, blood culture
Abstract
The article presents a bacteriological analysis of patients admitted to the Bukhara Regional Infectious Diseases Hospital from March 16, 2020 to February 02, 2022 with a diagnosis of COVID-19 coronavirus infection and confirmed SARS-CoV-2 infection (positive real-time RT-PCR, typical for SARS-CoV-2) Results are shown from fecal samples taken from patients Pr. Vulgaris, Pr. Mirobllis, Kl.phevmoniae, Enterobacter hafniae, from sputum samples of St. Pneumoniae, Can. viridans; S.epidermis, S.aureus were isolated from a blood sample. Most of the isolated microorganisms were sensitive to levofloxacin, amikacin, ciprofloxacin and cefoperazone sulbactam.
References
1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506.
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727–33.
3. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270–3.
4. WHO. Coronavirus disease 2019 (COVID-19)—situation report—51. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10.
5. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 202; 368 (6490):489–93.
6. Abdurashid Rahimovich Oblokulov, Zilola Zohirovna Husenova, Maksudjon Muzaffarovich Ergashev. (2021). Procalcitonin as an Indicator of Antibacterial Therapy in Covid-19. Annals of the Romanian Society for Cell Biology, Volume 25: Issue 3. 5220–5224.
7. Чориевич, Х.Д. и Фарходович Р.Ф. 2021. Клинико-эпидемия Характеристика Пациентов С Тяжёлой Пневмонии, Вызванной SARS-COV-2. ЦЕНТРАЛЬНОАЗИАТСКИЙ ЖУРНАЛ МЕДИЦИНСКИХ И ЕСТЕСТВЕННЫХ НАУК . (октябрь 2021 г.), 178–182. DOI: https://doi.org/10.47494/cajmns.vi0.373.
8. Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients. Clin Infect Dis 2020;71:713–20.
9. Elmurodova A. A. (2022). “Specific Features of the Hemostatic System in Covid-19”. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES 3, 82-85.
10. Obloqulov, A. R., Niyozov, G. E., Elmurodova, A. A., & Orifov, D. U. (2020). CLINICAL CHARACTERISTICS OF PATIENTS WITH COVID-19. Interdisciplinary Approaches to Medicine, 1(2), 40-43.
11. Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med 2020;76:97–9.
12. OblokulovA.R., Niyozov G.E. (2020). Clinical and epidemiological characteristics of patients with COVID-19 International Journal of Pharmaceutical Research, 12 (4), pp. 3749-3752.
13. Priya Nori et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge // Infect Contr and Hospital Epid, 2020. 1-5.
14. Niyazov G.E., Oblokulov A.R., Pondina A.I. et al. (2020) Clinical and epidemiological characteristics of COVID-19 patients // New Day in Medicine. No4 (32) 110-115 p.
15. Г, Худойдодова С., Фармонова М. В. 2021. «Covid-19 У Детей». Central Asian Journal of Medical and Natural Sciences, октябрь, 183-86. https://doi.org/10.47494/cajmns.vi0.374.
16. MacIntyre C.R., Chughtai A.A., Barnes M, et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a (H1N) // BMC Infect Dis. 2018. 18:637.doi.org/10.1186/s12879-018-3548-0.
17. Р., Облокулов А., Ниезов Г.Э., Ражабов А.Р. (2021). “Covid-Ассоциированная Коагулопатия У Пациентов Новой Коронавирусной Инфекции”. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, October, 124-30. https://doi.org/10.47494/cajmns.vi0.362.
18. Cataño-Correa JC, Cardona-Arias JA, Porras Mancilla JP, García MT (2021) Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020. PLoS ONE 16(7): e0254671. https://doi.org/10.1371/journal.pone.0254671
19. Mulcany M.E., McLoughlin R.M. Staphylococcus aureus and influenza A virus: patterns and coinfecrions. VBio. 2016. 7:e02068-16;
20. Canning B., Sennyake R.V., Burns D., Moran E, Dedicoat M. Post-influenza aspergillus ventriculitis // Clin Infect Pract 2020:100026. doi:10.1016/j.clinpr.2020.100026
21. Meier MA, Branche A, Neeser OL, et al. Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: a patient-level meta-analysis of randomized trials. Clin Infect Dis 2019; 69:388–96.
22. Meier MA, Branche A, Neeser OL, et al. Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: a patient-level meta-analysis of randomized trials. Clin Infect Dis 2019; 69:388–96.
23. De Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 2016; 16:819–27.
24. Timothy M Rawson, Luke S P Moore, Nina Zhu et al. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing linical Infectious Diseases, Volume 71, Issue 9, 1 November 2020, Pages 2459–2468.
25. Verroken A., Scohy A., Gerard L., et al. Co-infections in COVID-19 critically ill and antibiotic management: A prospective cohort analysis // Crit Care. 2020.24:410.
26. Hans H. Liu et al. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors. doi: 10.21203/rs.3.rs-79487/v1.
27. Liu HH, Yaron D, Piraino AS, Kapelusznik L. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors. Ann Clin Microbiol Antimicrob. 2021 Sep 25;20 (1):69.
28. Садиллоевна, Ж. А., Саётовна К. Д. (2021). Клиника – Лабораторная Характеристика Пациентов С Covid-19 И Предиктор Антибактериальной Терапии. ЦЕНТРАЛЬНО-АЗИАТСКИЙ ЖУРНАЛ МЕДИЦИНСКИХ И ЕСТЕСТВЕННЫХ НАУК, 81-86. https://doi.org/10.47494/cajmns.vi0.354
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727–33.
3. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270–3.
4. WHO. Coronavirus disease 2019 (COVID-19)—situation report—51. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10.
5. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 202; 368 (6490):489–93.
6. Abdurashid Rahimovich Oblokulov, Zilola Zohirovna Husenova, Maksudjon Muzaffarovich Ergashev. (2021). Procalcitonin as an Indicator of Antibacterial Therapy in Covid-19. Annals of the Romanian Society for Cell Biology, Volume 25: Issue 3. 5220–5224.
7. Чориевич, Х.Д. и Фарходович Р.Ф. 2021. Клинико-эпидемия Характеристика Пациентов С Тяжёлой Пневмонии, Вызванной SARS-COV-2. ЦЕНТРАЛЬНОАЗИАТСКИЙ ЖУРНАЛ МЕДИЦИНСКИХ И ЕСТЕСТВЕННЫХ НАУК . (октябрь 2021 г.), 178–182. DOI: https://doi.org/10.47494/cajmns.vi0.373.
8. Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients. Clin Infect Dis 2020;71:713–20.
9. Elmurodova A. A. (2022). “Specific Features of the Hemostatic System in Covid-19”. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES 3, 82-85.
10. Obloqulov, A. R., Niyozov, G. E., Elmurodova, A. A., & Orifov, D. U. (2020). CLINICAL CHARACTERISTICS OF PATIENTS WITH COVID-19. Interdisciplinary Approaches to Medicine, 1(2), 40-43.
11. Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med 2020;76:97–9.
12. OblokulovA.R., Niyozov G.E. (2020). Clinical and epidemiological characteristics of patients with COVID-19 International Journal of Pharmaceutical Research, 12 (4), pp. 3749-3752.
13. Priya Nori et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge // Infect Contr and Hospital Epid, 2020. 1-5.
14. Niyazov G.E., Oblokulov A.R., Pondina A.I. et al. (2020) Clinical and epidemiological characteristics of COVID-19 patients // New Day in Medicine. No4 (32) 110-115 p.
15. Г, Худойдодова С., Фармонова М. В. 2021. «Covid-19 У Детей». Central Asian Journal of Medical and Natural Sciences, октябрь, 183-86. https://doi.org/10.47494/cajmns.vi0.374.
16. MacIntyre C.R., Chughtai A.A., Barnes M, et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a (H1N) // BMC Infect Dis. 2018. 18:637.doi.org/10.1186/s12879-018-3548-0.
17. Р., Облокулов А., Ниезов Г.Э., Ражабов А.Р. (2021). “Covid-Ассоциированная Коагулопатия У Пациентов Новой Коронавирусной Инфекции”. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, October, 124-30. https://doi.org/10.47494/cajmns.vi0.362.
18. Cataño-Correa JC, Cardona-Arias JA, Porras Mancilla JP, García MT (2021) Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020. PLoS ONE 16(7): e0254671. https://doi.org/10.1371/journal.pone.0254671
19. Mulcany M.E., McLoughlin R.M. Staphylococcus aureus and influenza A virus: patterns and coinfecrions. VBio. 2016. 7:e02068-16;
20. Canning B., Sennyake R.V., Burns D., Moran E, Dedicoat M. Post-influenza aspergillus ventriculitis // Clin Infect Pract 2020:100026. doi:10.1016/j.clinpr.2020.100026
21. Meier MA, Branche A, Neeser OL, et al. Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: a patient-level meta-analysis of randomized trials. Clin Infect Dis 2019; 69:388–96.
22. Meier MA, Branche A, Neeser OL, et al. Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: a patient-level meta-analysis of randomized trials. Clin Infect Dis 2019; 69:388–96.
23. De Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 2016; 16:819–27.
24. Timothy M Rawson, Luke S P Moore, Nina Zhu et al. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing linical Infectious Diseases, Volume 71, Issue 9, 1 November 2020, Pages 2459–2468.
25. Verroken A., Scohy A., Gerard L., et al. Co-infections in COVID-19 critically ill and antibiotic management: A prospective cohort analysis // Crit Care. 2020.24:410.
26. Hans H. Liu et al. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors. doi: 10.21203/rs.3.rs-79487/v1.
27. Liu HH, Yaron D, Piraino AS, Kapelusznik L. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors. Ann Clin Microbiol Antimicrob. 2021 Sep 25;20 (1):69.
28. Садиллоевна, Ж. А., Саётовна К. Д. (2021). Клиника – Лабораторная Характеристика Пациентов С Covid-19 И Предиктор Антибактериальной Терапии. ЦЕНТРАЛЬНО-АЗИАТСКИЙ ЖУРНАЛ МЕДИЦИНСКИХ И ЕСТЕСТВЕННЫХ НАУК, 81-86. https://doi.org/10.47494/cajmns.vi0.354
Published
2022-04-09
How to Cite
Raximovich, O. A., Sadilloyevna, J. A., Abdulloyevna, M. S., & Farxodovich , R. F. (2022). Microbiological Indicators of Patients with Confirmed Sars-Cov-2 - Infection. Central Asian Journal of Medical and Natural Science, 3(2), 289-294. Retrieved from https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/664
Section
Articles
